Something unusual is happening in cannabis policy right now. Groups that almost never agree on anything are suddenly speaking the same language. Major medical organizations, Trump-aligned political operatives, and even cannabis industry advocates, all of them are applauding the same development: marijuana’s move toward Schedule III. At first glance, it reads like progress. Maybe it… Keep Reading
In 2025, cannabis is everywhere and nowhere at the same time. Everywhere in the sense that you can buy it legally in glittery storefronts, order it for delivery like pizza, see it advertised on billboards, hear politicians brag about the tax revenue, and watch corporate executives talk about “innovation” with the same straight face Big… Keep Reading
BHO started as a hydrocarbon experiment, often using raw butane and DIY rigs that carried risks. Even with today’s refined, regulated extraction systems, solventless options like rosin and hash remain the purest way to consume cannabis without chemical solvents or complicated gear. Before Colorado had dispensaries, regulations, compliance trackers, or certificate-of-analysis stickers, it already had… Keep Reading
When President Donald Trump announced that he would sign an executive order moving marijuana from Schedule I to Schedule III, he didn’t frame it as a cultural breakthrough or a political victory. He framed it as medicine. There were no weed jokes, no talk of freedom, no nods to cannabis culture. Instead, Trump spoke about… Keep Reading
Florida Gov. Ron DeSantis’ administration diverted more than $35 million in taxpayer funds that investigators say were used to influence last year’s ballot fights over abortion and recreational cannabis, according to a months-long investigation by the Miami Herald and Tampa Bay Times. The money, originally allocated for healthcare, child welfare and opioid recovery programs, was… Keep Reading
President Donald Trump publicly acknowledged on Monday that his administration is actively considering reclassifying cannabis under federal law, saying the current Schedule I status blocks medical and scientific research. “A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify,” Trump… Keep Reading
Trump is reportedly weighing a directive that would push federal agencies to move cannabis from Schedule I to Schedule III, but the White House says no final decision has been made. If it happens, Schedule III would bring meaningful 280E tax relief to state-legal operators and ease some research barriers, yet it would still leave… Keep Reading
The Mylar bags were whispering again. That thin, plastic whine like cheap toys haunted by bad branding decisions. They twitched on the table under the kitchen light, a dozen neon rectangles posing like they were auditioning for a merch drop no one asked for. One of them—holographic alien, oversized blunt, eyes too big to be… Keep Reading
Who would have imagined that Latin America’s largest cannabis expo would take place in a country whose Congress still treats the subject with deep suspicion? Yet that is what unfolded as ExpoCannabis Brasil wrapped its third edition, the most ambitious so far, revealing a cannabis culture in Brazil that is expanding despite political obstacles. One… Keep Reading
This article is an adapted version of the Cannabis Confidential newsletter. It’s a rare session that I’ll step away from the screens, particularly with so much going on, year-end approaching and the industry on edge. As I pride myself on conducting exhaustive due diligence, I drove across the river this morning to join Ascend CEO… Keep Reading
